Vitrasert

Active Ingredient(s): Ganciclovir
FDA Approved: * March 4, 1996
Pharm Company: * BAUSCH AND LOMB
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vitrasert Overview

Ganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections. A prodrug form with improved oral bioavailability (valganciclovir) has also been developed. Ganciclovir was approved for medical use in 1989.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 References 5.1 Further reading Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ...

Read more Vitrasert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ganciclovir

Recent Vitrasert Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Ganciclovir or a similar ingredient: (5 results)

• CYTOVENE Ganciclovir
• GANCICLOVIR
• ZIRGAN Ganciclovir
• VALCYTE Valganciclovir
• VALGANCICLOVIR